Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Tumors are the result of what?
|
DYSregulated growth- a clone of cells that replicate
|
|
Cancer and tumors
|
uncontrolled tumor growth
UNCONTROLLED |
|
Malignant vs. Bening Tumor
|
Not invasive, not capable of indefinite growth
|
|
What are the three types of cancer?
|
1) Carcinoma
2) Lymphoma/Leukemia Cells 3) Sarcomas |
|
Carcinoma
|
Endodermal or ectodermal tissue
Skin, epithelial lining of organs- breast, colon, lung, prostate (~80%) |
|
Lymphomas/Leukemia
|
from HEMATOPOIETIC CElls (myeloid vs. lymphoid leukemia)
Lymph nodes lymphode cell |
|
Sarcoma
|
From mesodermic tissue- BONE
|
|
What are 3 causes of cancer?
|
1) Induce cell proliferation
2) loss of tumor suppressor gene function 3) loss of control of cell death- bcl2 |
|
Cancer is a result of
|
1) spontaneous or inherited mutation
2) Chemical carcinogens 3) virus transformation |
|
Genes that were normal before them became an ONCOGENES
|
PROTO oncogenes
|
|
What are mutations that induce cell proliferation
|
A) Growth factor receptors (NEU)
Breast cancer- is over production of NEU B) Tyrosine kinases in GF signaling (Src, abl) C) GTP-binding proteins involved in growth induction |
|
Proteins involved in mutation in tumor suppressor genes (mutates to lose inhibition of cell growth)
|
p53, RB
These normally regulate cell growth- but don't regulate as they should |
|
Gene amplification of genes controlling cell death mutation involves what protein
|
bcl2
|
|
Anti-apoptotic protein
|
bcl2
Inhibits apoptosis and promotes growth Increase bcl2, increase tumor generation (Lymphoma) |
|
The development of cancer requires
|
MULTIPLE HITS
|
|
15% of all cancers are from
|
Viruses that integrate into genome and induce transformation
|
|
What are examples of viruses that cause TUMOR
|
HPV- cervical
Epstein Barr Virus nasopharyngeal carcinoma Burkitt lymphoma Hepatitis B virus- Liver cancer |
|
Human T-lymphotropic virus (HTLV)
|
human, single-stranded RNA retrovirus that causes T-cell leukemia and T-cell lymphoma in adult
|
|
How do we know that a protective response can be mounted against tumors?
|
Tumor rejection antigens
Tumor specific antigens Tumor associated antigens |
|
Why won't response to irradiated tumor will not eliminate unrelated tumors of different cell types?
|
Response to UNIQUE tumor rejection ANTIGENS elmiminates tumor
|
|
Response to unique tumor rejection antigen
|
ELIMINATES TUMOR
|
|
Tumor antigen CEA
|
reactivates embroynic gene xpression in tumor cell- present new antigens to adult immun esystem
|
|
Overexpress normal self-peptide by a tumor cell changes peptide presentation density allowing T cell recognition
|
HIGHER levels of expression
|
|
If you have mutated peptide, then you have
|
alterations in CHO
Alteration in glycosylation machinery- alter structure, making it susceptible to different ways of cleaving. Different cleaves, different MHC T cell presentation (foreign) |
|
MUC-1
|
underglycosylated mucin
Different kinds: Over and differently glycosylated Exposure of cleavage site for processing, recognition by acid residue sequences |
|
Three immune responses to tumors?
|
CTL killing
Nk Killing Macropahges secreting stuff |
|
CTL killing involves what?
|
LAK cells
|
|
LAK cells
|
Lymphokine activated killer cells are white blood cells that help to identify and destroy cancer cells in the body.
|
|
Nk killing occurs
|
directly or via FCR
direct or ADCC (FcR) |
|
What do macrophages secrete
|
lyctic enzymes, NO, Ros, TNF alpha
|
|
Mechanisms by which tumors escape immune recognition
|
1) Antigenic modulation
Antibody against tumor-cell surface antigens can induce ENDOCYTOSIS and DEGRADATION of antigen Immune selection of antigen-loss variants |
|
Antigenic moduation
|
INGEST
CLUSTER down regulate now the immune system can no longer see it Protected So ab' is not enough to generate Complement activation Not in right place to allow for phagocyte or NK mediated killing |
|
Immune may also generate proteases
|
ECTOpreateases that cleave up antigen
|
|
Tumors have low immunogenicity
|
Down regulate
Loss of HLA class I expression in prostate gland |
|
Tumors and HLA class I
|
lymphocytes coming in to combat tumor
No HLA 1 to present foreign peptide Must have CD8s to work |
|
Macrophages and low immunogenicity of tuomrs
|
The successful Macrophages against tumor cells secrete soluble TNF receptor
Kill tumors by secreting TNF alpha, induces apoptosis in tumor cells Tumor cells clip that off by clipping protease No longer have receptor- no apoptosis TNF-alpha binding- neutralize |
|
Low immunogenicity of Tumors because they don't have
|
PEPTIDE
MHC ligand Adhesion molecules Co-stimulatory molecules |
|
Tumors escape immune suppression DIRECTLY via
|
TGF-beta by tumor cells inhibits T cells directly
Blocking factors- like sTNF alpha receptor |
|
How are NK cells activated?
|
Tumor specific antibody
binds to tumor cell NK cells with Fc receptors (CD16) activated to kill tumor cells |
|
If tumor specific Ab has CONJUGATED
|
Cojugate is internalized, killing the cell
|
|
Tumor specific antibody conjugated to RADIONUCLIDE
|
radioactive antibody binds to the tumor cell
Radiation kills tumor cell and neighbor tumor cell |
|
Monoclonal Antibodies-
|
AVASTIN
HERCEPTIN RITUXAN |
|
Presence of TRA and no accompanying costimulatory molecules
|
Tumor rejection antigen
Can't turn on naive CD8 T cells Anergic Tumor grows progressively |